Kopran (KOPRAN)
STALWARTFairStock Score: 22/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 1/1
Key Financials
| Current Price | ₹161.05 |
| Market Cap | ₹636.55 Cr |
| P/E Ratio | 38.46 |
| ROCE | 9.75% |
| ROE | 4.89% |
| Dividend Yield | 2.28% |
| Profit Growth | -10.19% |
| Debt/Equity | 0.31 |
| Sales Growth | 16.87% |
| Promoter Holding | 44.42% |
| 52-Week Range | ₹107 — ₹219 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹86.22 |
Kopran trades with a P/E ratio of 38.46, ROCE of 9.75%, ROE of 4.89%, profit growth of -10.19%, debt-to-equity of 0.31. The FairStock Score of 22/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer